Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 444, 31 (2 November 2006) | doi:10.1038/444031c; Published online 1 November 2006
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Two Post-Doctoral Position In Nanomedicine
- Fondazione IRCCS Istituto Neurologico "Carlo Besta" (FINCB)
- Via Celoria n.11, 20133 Milano, Italy
Faculty Positions
- University of Texas Medical Branch
- Galveston, TX United States
No room for complacency on drug resistance in Africa
Ian M. Hastings1, David G. Lalloo1 & Saye H. Khoo2
- Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
- Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3BX, UK
Your News Feature "Staying the course" (Nature 442, 617–619; 2006) offered a welcome dose of optimism in the debate about mass deployment of antiretroviral therapies in Africa, by arguing that this had not yet created an epidemic of drug-resistant HIV. But although everyone in the field has been delighted by initial studies suggesting high adherence, we must not be complacent.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Non-proteolytic inactivation of geminin requires CDK-dependent ubiquitinationNature Cell Biology Letter (01 Mar 2004)
